Fibrinolytic Activity of 6-Keto-Prostaglandin E₁

• References

• 1 Utsunomiya T, Krausz MM, Valeri CR, Shepro D, Hechtman HB. Treatment of pulmonary embolism with prostacyclin. Surgery 1980; 88: 25-30
• 2 Dembińska-Kieć A, Kostka-Trabka E, Gryglewski RJ. Effect of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans. Thromb Haemostas 1982; 47: 190
• 3 Wong PY-K, Malik KU, Desiderio DM, McGiff JC, Sun FF. Hepatic metabolism of prostacyclin (PGI₂) in the rabbit: Formation of a potent novel inhibitor of platelet aggregation. Biochem Biophys Res Comm 1980; 93: 486-494
• 4 Kaulla vonK, Schultz RL. Methods for evaluation of human fibrinolysis: Studies with two combined techniques. Am J Clin Pathol 1958; 29: 104-112
• 5 Skuballa W, Vorbrüggen H. Synthesis of Ciloprost (ZK 36374): A chemically stable and biologically potent prostacyclin analog. Advances in Prostaglandin, Thromboxane and Leukotriene Research. Samuelsson B, Paoletti R, Ramwell P. (Eds) Raven Press; New York: 1983. 11 299-305